Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

52 results about "Protease digestion" patented technology

1. Proteases. Digestion of proteins is initiated by pepsin in the stomach, but the bulk of protein digestion is due to the pancreatic proteases. Several proteases are synthesized in the pancreas and secreted into the lumen of the small intestine.

Method for quantifying active orexin a

A method for quantifying active orexin A in a specimen, comprising: a step of contacting the specimen with a monoclonal antibody that recognizes the C-terminal side of orexin A to separate orexin A species; a step of digesting the separated orexin A species with a protease to obtain a peptide consisting of an amino acid sequence of SEQ ID NO: 1; and a step of performing mass spectrometry on the peptide.
Owner:EISAI R&D MANAGEMENT CO LTD

Peptides

A composition is disclosed comprising a plurality of peptides obtained by the protease digestion or hydrolysis of a plant extract such as rapeseed meal (RSM) or partially defatted rapeseed cake (RSC) obtained from Brassica napus. The rapeseed extract may be preferably digested to produce peptides of 2-25 residues in length using at least two endopeptidases such as a combination of subtilisin (Alcalase RTM), bacillolysin and / or actinidin. The use of Protamex RTM (subtilisin and bacillolysin) and of Flavourzyme RTM is disclosed. The composition may be used as a medicinal anti-inflammatory treatment for example of diabetic ulcers, wounds, colitis and bowel diseases including ulcerative colitis and Crohn’s disease. The composition may be suitable for use as a nutraceutical or as a skin cosmetic. Methods of preparation of a peptide composition by the proteolytic digestion of rapeseed extracts are disclosed.
Owner:VALOGEN BIOSCIENCES LIMITED

Preparation method and application of GHK oligopeptide

The invention discloses a preparation method and application of GHK oligopeptide, and belongs to the technical field of biology. According to the method, a nucleotide sequence of the GHK polypeptide is obtained by designing tandem repeat GHK polypeptide ([GHK] 63) and combining preferred codons of bacillus subtilis to optimize a polypeptide coding gene. The GHK oligopeptide is subjected to recombinant expression in bacillus subtilis by utilizing a genetic engineering technology, the obtained recombinant protein is not easy to form an inclusion body and does not contain endotoxin, and the high-yield GHK oligopeptide is obtained after separation, purification and protease digestion treatment. According to the GHK oligopeptide preparation method provided by the invention, extra optimization treatment does not need to be carried out on tandem repeat GHK polypeptides, the yield of the GHK oligopeptide is improved, the whole production process is simplified, the cost is low, and the method is suitable for large-scale production of blue copper peptides and has wide application prospects in the fields of medicines, medical beauty and the like.
Owner:TIANJIN XUN ENZYME BIOTECHNOLOGY CO LTD

Peptides prepared from a plant extract obtained by protease digestion

We disclose a process for the preparation of a plurality of plant derived peptides; compositions comprising said plurality of peptides; medicaments and cosmetics comprising said peptides and their use in the treatment of cutaneous skin conditions such as wound healing and inflammatory disease or conditions.
Owner:VALOGEN BIOSCIENCES LIMITED

Methods for rapid separation and purification of DNA topological forms

Methods are provided for the isolation and analysis of circular DNA from complex samples, based on the topology of the DNA molecule. A sample comprising DNA species is combined with a chaotropic dense salt solution. A fraction containing the circular DNA of interest is isolated and dialyzed to remove excess salt. In some embodiments salt gradients are generated by ultracentrifugation in the absence of intercalating dyes, e.g. ethidium bromide; and in the absence of protease digestion. The circular DNA thus isolated is substantially pure, e.g. greater than about 75%, greater than about 80%, greater than about 90%, greater than about 95% of DNA in the isolated fraction is comprised of circular DNA.
Owner:BOARD OF RGT THE UNIV OF TEXAS SYST +1

A method for preparing and applying plant sulfonated peptide PSK based on synthetic biology

This invention discloses a method for preparing and applying plant sulfonated small peptide PSK based on synthetic biology, belonging to the field of biotechnology. Based on the design concept of synthetic biology, this invention constructs an orthogonal synthetic system composed of genetic code expansion technology and SUMO fusion protease digestion technology. A specific PSK dotted vector and a pUltra-sY vector are co-transformed into *E. coli* to construct a genetically engineered strain. The sulfonated small peptide PSK precursor is expressed in this genetically engineered strain, and mature plant sulfonated small peptide PSK is obtained through specific hydrolysis by SUMO protease. This method significantly improves the synthesis efficiency and purity of sulfonated small peptides and has broad application prospects in agricultural production and biotechnology.
Owner:ZHEJIANG UNIV

Kit for rapidly purifying viral nucleic acid from different types of liquid biological samples and extraction method

The invention discloses a kit for rapidly purifying viral nucleic acid from different types of liquid biological samples and an extraction method. The kit comprises the following reagents: a lysis binding solution, a protease k solution, magnetic beads, a washing solution I, a washing solution II and an eluent. When the kit is used for extracting the viral nucleic acid, the three steps of protease K digestion, lysate lysis and nucleic acid combination are simultaneously carried out, the operation steps are greatly simplified, the extraction time of the viral nucleic acid is shortened, and the obtained high-quality viral nucleic acid can be directly applied to downstream experiments such as PCR (Polymerase Chain Reaction), RT-PCR (Reverse Transcription-Polymerase Chain Reaction), qPCR (Quantitative Polymerase Chain Reaction) and the like.
Owner:SUZHOU YINGZE BIOMEDICAL TECH CO LTD

Acoustic extracellular matrix hydrogels and their uses

This invention provides a method for forming a mammalian acoustic extracellular matrix (ECM) hydrogel without the use of acidic or alkaline solutions or protease digestion, as well as the resulting acoustic ECM hydrogel. [Solution] A method for producing an extracellular matrix (ECM) hydrogel is provided, comprising using ultrasonic frequencies to solubilize mammalian ECM in a liquid to produce a liquid-phase acoustic ECM hydrogel.
Owner:UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION

HER-2 targeted bispecific compositions and methods for making and using the same

Disclosed herein are polypeptides, and methods of making and using such polypeptides, that comprise a bispecific antibody construct covalently linked to an extended recombinant polypeptide comprising a barcode fragment releasable from said polypeptide upon digestion by a protease, and a Release Segment that can be proteolytically cleaved wherein said cleavage releases the bispecific antibody construct from the extended recombinant polypeptide.
Owner:AMUNIX PHARMACEUTICALS INC

Antibodies and methods of use thereof

Provided herein is an antibody that specifically binds to a peptide antigen.Methods for detecting, isolating or quantifying peptide antigens are also provided.In some embodiments, peptide antigens are released from dystrophin or micro-dystrophin by protease digestion.Methods for detecting or quantifying micro-dystrophin or dystrophin in a sample using antibodies are also provided.In some embodiments, the methods described herein are used to monitor the expression of micro-dystrophin in subjects receiving nucleic acid-based therapy.
Owner:REGENXBIO INC

Method of pretreating blood sample

A method of pretreating a blood sample for measuring ATP of a pathogenic microorganism in blood, comprising: preparing a pellet of platelets and the pathogenic microorganism from the blood sample; and subjecting the pellet of platelets and the pathogenic microorganism to the following steps (A) to (C) in any order (including multiple simultaneous steps). A method of pretreating a cultured blood sample, wherein the method is a simplified method, does not comprise the following step (A), and comprises the steps (B) and (C) only simultaneously performed. (A) digesting cell membrane proteins of the platelets with a protease; (B) swelling the platelets in a hypotonic solution; and (C) disrupting cell membranes of the platelets with a detergent solution under a condition of suppressing an effect on the pathogenic microorganism.
Owner:LABTECHS INC

Method for simultaneously enriching disordered protein and combining three-dimensional genome structure

The invention provides a method for simultaneously enriching disordered protein and a combined three-dimensional genome structure thereof, and relates to the technical field of molecular biology. The method comprises the following steps: after cross-linking cells with formaldehyde and disuccinimide glutaric acid (DSG), carrying out enzyme digestion treatment, terminal repair and adjacent connection by using restriction enzyme Dpn II; after connection, ultrasonically breaking the cell nucleus to obtain an ultrasonically broken product, dividing the ultrasonically broken product into two parts, capturing DNA and a protein complex of one part of the product by using biotinylated isoxazole, digesting protein by using protease, extracting and purifying the DNA, and carrying out library building and sequencing on the purified DNA; the other part of the product is treated by nuclease, protein is extracted, and then protein spectrum analysis is carried out. The method can realize whole genome non-destructive detection of the disordered protein and the three-dimensional structure of the chromatin combined with the disordered protein, and provides an effective way for structural analysis of the disordered protein.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Method for quantifying active orexin A

A method for quantifying active orexin A in a sample, the method comprising: a step in which the sample is brought into contact with a monoclonal antibody that recognizes the C-terminal side of orexin A to isolate orexin class A; a step for digesting the separated orexin class A with a protease to obtain a peptide comprising the amino acid sequence represented by SEQ ID NO: 1; and a step for performing mass spectrometry on the peptide.
Owner:EISAI R&D MANAGEMENT CO LTD

Rapid in-situ hybridization detection method and application thereof

The embodiment of the invention relates to the technical field of nucleic acid detection, in particular to a rapid in-situ hybridization detection method and application thereof, and the rapid in-situ hybridization detection method comprises the following steps: S1, preparing an anti-DNA-RNA heterozygote antibody; s2, carrying out in-situ hybridization detection; the method comprises the steps of dewaxing, protease digestion, probe hybridization, anti-DNA-RNA heterozygote antibody immunization, DAB (or fast red) color development, hematoxylin dye liquor redyeing, blue returning, dehydration, transparentizing, conventional mounting and the like. According to the present invention, the monoclonal antibody against the DNA-RNA heterozygote mouse is matched, the combination of the antibody and the DNA-RNA heterozygote molecule has high specificity and high sensitivity, the DNA or RNA sequence specifically recognized by the probe in the cell can be specifically recognized and detected, and the positive high expression is provided during the DNA-RNA heterozygote detection; the antibody can be applied to the detection and screening fields of fluorescence in situ hybridization detection, ELISA detection, antibody chip preparation, flow cytometry and the like, and is beneficial to obtaining accurate evaluation and detection results.
Owner:HANGZHOU BAIYIN BIOTECHNOLOGY CO LTD

DNA / RNA co-extraction method and kit based on aqueous two-phase-temperature-induced phase separation

The application discloses a DNA / RNA co-extraction method and kit based on a double-water-phase temperature-induced phase separation, which utilizes polyethylene glycol-sodium citrate to form a primary double-water-phase system at 18-25 DEG C, and by adding an ionic liquid modified temperature-sensitive polymer (IL-NIPAM) with a LCST of 32 DEG C plus or minus 1 DEG C, the IL-NIPAM selectively binds with RNA, and the separation of RNA and DNA in a biological sample is realized by temperature regulation. The DNA / RNA co-extraction kit includes a double-water-phase premix, and the IL-NIPAM is added in the double-water-phase premix in advance or during use, and the use concentration of the IL-NIPAM is 0.5-1.5% w / w. The method does not need proteinase K digestion and does not need to add organic solvents, and can quickly and efficiently recover DNA, mRNA and miRNA, and is suitable for the co-extraction of nucleic acids from trace samples such as fingertip blood, dry blood spots and FFPE sections, and is suitable for automation and large-scale production.
Owner:QINGDAO RUISIDE MEDICAL LABORATORY CO LTD

Method for producing transparent stained specimen of medium and large adult fish individuals

The present invention provides a method for making a transparent stained specimen of medium and large adult fish individuals, belonging to the field of specimen making. The method includes sample pretreatment, specimen making, and specimen preservation; the specimen making includes scaling and skinning, fixing with absolute ethanol, bone staining, pretreatment for clearing, and clearing; the present invention adopts the method of precise targeted intramuscular injection of trypsin digestion solution, which can accelerate the digestion process and thus shorten the production process; the present invention immerses the digested specimen successively in two potassium hydroxide-water-glycerol-diethylene glycol systems, and then transfers it to diethylene glycol-glycerol to complete the clearing, which can not only make the clearing faster and more complete, but also exclude the interference of histamine, pigments, etc., so that the spatial structure of the internal bones of the fish body can be observed through the cleared soft tissues without removing the soft tissues, and a transparent bone stained specimen of adult fish individuals with a body length of 10-50 cm and a body weight of 0-1 kg is successfully made.
Owner:YELLOW SEA FISHERIES RES INST CHINESE ACAD OF FISHERIES SCI

Peptide analyzing method

In the analysis method according to the present invention, a predetermined peptide is separated by immunoprecipitation using an antibody which specifically binds to either an N-terminus or a C-terminus of the predetermined peptide. The separated predetermined peptide is digested with a protease to prepare peptide fragments, and among the peptide fragments, a peptide fragment at a terminus opposite to a terminus binding to the antibody is mass-spectrometrically detected.
Owner:SHIMADZU CORP

Method for efficiently preparing high-purity NudCD3 protein in in-vitro eukaryotic cells

The invention provides a method for efficiently preparing high-purity NudCD3 protein in an in-vitro eukaryotic cell. The method comprises the following steps: synthesizing a target gene; carrying out enzyme digestion on the target gene and the pLEXmMBP vector, and connecting to obtain a recombinant vector; transforming the recombinant vector into competent cells, culturing, and extracting plasmids; transfecting an HEK 293F cell, culturing, and collecting the cell; resuspending the cells in a lysis buffer solution, carrying out ultrasonication and centrifugation, and taking a supernatant; and carrying out affinity chromatography column purification, Prescission protease digestion and molecular sieve purification to finally obtain the NudCD3 protein with the purity of more than 90%. The problems that in the prior art, NudCD3 protein is difficult to express in quantity and insufficient in purity are solved, high-purity protein is provided for structural biology research, drug screening and antibody preparation, and the method has the advantages of being easy to operate, high in yield, high in protein stability and the like.
Owner:ANHUI UNIV

A method for enhancing the stability of alpha-synuclein aggregates

The invention discloses a method for enhancing the stability of alpha-synuclein aggregates. Trypsin and proteinase K (PK) digestion experiments are used to compare and analyze the stability differences of alpha-Syn aggregates formed by incubation with phosphate buffer solution (PBS), plasma of healthy controls (HC) and plasma of PD patients, so as to provide an experimental basis for exploring the differences in different neurotoxicity of alpha-Syn aggregates formed by incubation under different conditions.
Owner:AFFILIATED HOSPITAL OF GUILIN MEDICAL UNIV

Barcoded XTEN peptides and their compositions, as well as their preparation and use methods

This document discloses polypeptides comprising an extended recombinant polypeptide (XTEN) containing multiple overlapping sequence motifs and one or more barcode fragments, which are releasable upon protease digestion and detectable from all other protease-releasable fragments. Some embodiments of these polypeptides also comprise a bioactive polypeptide, wherein advantageous embodiments include a protease-cleavable releasable segment capable of cleaving the link between the XTEN polypeptide and the bioactive polypeptide. Methods for preparing and using the polypeptides are also disclosed.
Owner:AMUNIX PHARMACEUTICALS INC

A derivative of insulin aspart and a method for preparing and using the same

A derivative of insulin aspart and a method for preparing the same, the derivative comprising a fusion protein of a green fluorescent protein folding unit and an insulin aspart precursor or an active fragment thereof. The fusion protein is expressed in a significantly increased amount, the insulin aspart precursor protein in the fusion protein is folded correctly and has biological activity. Furthermore, the green fluorescent protein folding unit in the fusion protein can be digested by a protease into small fragments, and has a large difference in molecular weight compared to the target protein, and is easy to separate. A method for preparing insulin aspart and an intermediate using the fusion protein is also provided.
Owner:NINGBO KUNPENG BIOTECH CO LTD

Method for quantifying active orexin a

A method for quantifying active orexin A in a specimen, comprising: a step of contacting the specimen with a monoclonal antibody that recognizes the C-terminal side of orexin A to separate orexin A species; a step of digesting the separated orexin A species with a protease to obtain a peptide consisting of an amino acid sequence of SEQ ID NO: 1; and a step of performing mass spectrometry on the peptide.
Owner:EISAI R&D MANAGEMENT CO LTD

Preparation method of fat acellular extracellular matrix hydrogel

The invention belongs to the technical field of biological tissue engineering, and discloses a fat acellular extracellular matrix hydrogel preparation method, which comprises: (1) cutting cleaned fresh fat into pieces, and repeatedly freezing and thawing with a hypertonic salt solution; (2) homogenizing the frozen and thawed fat at low temperature, and collecting and precipitating; (3) re-suspending the precipitate by using PBS, oscillating in a shaking table, centrifuging at room temperature, and collecting the precipitate again; (4) carrying out degreasing and decellularization treatment on the collected precipitate by using a composite eluent; and (5) washing the precipitate with isopropanol for 24 hours, finally repeatedly washing the precipitate with distilled water, and collecting the precipitate, namely the fat acellular matrix. And (6) digesting the fat extracellular matrix with pepsin hydrochloride, and adjusting the pH value to be neutral with sodium hydroxide to obtain the fat extracellular matrix hydrogel. According to the preparation method of the fat extracellular matrix hydrogel, biological enzyme and high-speed centrifugation are not needed in the decellularization stage, the technology is simple, time consumption is short, the yield is high, the fat extracellular matrix prepared through the method is easy to digest, and the prepared hydrogel solution is uniform, good in injectability and capable of being used for production of a filling material for injection.
Owner:CHIMEDICAL UNIVERSITY

Barcoded XTEN polypeptides and compositions thereof, and methods for making and using the same

Disclosed herein are polypeptides comprising an extended recombinant polypeptide (XTEN) comprised of a plurality of overlapping sequence motifs and one or more barcode fragments releasable upon protease digestion and detectable from ail other proteolytic-ally releasable fragments. Certain embodiments of these polypeptides further comprise a biologically active polypeptide, wherein advantageous embodiments thereof comprise a releasable segment capable of proteolytic cleavage that cleaves the linkage between the XTEN polypeptide and the biologically active polypeptide. Methods of making and methods of using said polypeptides are also disclosed.
Owner:AMUNIX PHARMACEUTICALS INC

Antibodies and methods of using thereof

Provided herein are antibodies that specifically bind to a peptide antigen. Also provided are methods of detecting, isolating or quantifying the peptide antigen. In some embodiments, the peptide antigen is released from dystrophin or microdystrophin by protease digestion. Also provided are methods for detecting or quantifying microdystrophin or dystrophin in a sample using the antibodies. In some embodiments, a method described herein is used to monitor the expression of microdystrophin in a subject that has been administered a nucleic acid based therapy.
Owner:REGENXBIO INC

CD71-targeting ROS responsive micelle as well as preparation method and application thereof

The invention belongs to the field of medicines, and particularly relates to a CD71-targeting ROS responsive micelle as well as a preparation method and application thereof. In order to improve the efficacy of an anti-tumor drug in treating AML patients and reduce toxic and side effects, the invention provides a nano drug delivery system, namely a CD71-targeted ROS responsive micelle, which comprises the following components: amphiphilic molecules with ROS response, DSPE-PEG-DT7 and an anti-tumor drug. The micelle provided by the invention adopts a small molecule polypeptide ligand, so that competition with endogenous Tf is avoided, the micelle has protease digestion resistance, and the targeting property in blood and the in-vivo stability are improved; an amphiphilic block containing ROS responsiveness is introduced as a micelle skeleton, so that specific drug release in AML cells is realized, the curative effect is enhanced, and the side effect is reduced; aiming at AML (acute myelogenous leukemia) cells with ROS (reactive oxygen species) rise caused by FLT3-ITD mutation, the micelle disclosed by the invention can be used for effectively releasing drugs and generating a stronger drug effect reaction.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

Sample DNA rapid extraction method

The invention relates to the technical field of borosilicate glass, in particular to a sample DNA (deoxyribonucleic acid) rapid extraction method which comprises the following steps: step S1, sample pretreatment: taking 20-100 mu L of liquid sample or 25-50 mg of solid sample, adding 100-200 mu L of pretreatment liquid with the pH value of 7.5-8.0, and uniformly mixing by vortex for 10-30 seconds; s2, synergistic cracking and adsorption: adding 150-200 [mu] L of a composite cracking solution and 10-20 [mu] g of modified diatomite into the pretreatment solution, incubating at 55-60 DEG C for 3-4 min, and reversing and uniformly mixing twice during incubation; s3, impurity removal: adding 150-200 [mu] L of a washing liquid I, standing at room temperature for 1 min, and pouring to remove a supernatant; then adding 200 [mu] L of a washing liquid II, standing for 30 s, and dumping to remove the supernatant. By optimizing the composite lysate, the modified diatomite and reaction conditions, rapid DNA extraction of which the whole process is less than or equal to 8 minutes without protease K digestion and high-speed centrifugation is realized, the method has wide sample adaptability, high automation compatibility and stable DNA yield and purity, the extraction efficiency is greatly improved, and the operation cost and threshold are reduced.
Owner:CHONGBOT BIOTECHNOLOGY (CHANGZHOU) CO LTD

Automatic extraction device for large-volume free nucleic acid by centrifugal column method

An automatic extraction device for large-volume free nucleic acid through a centrifugal column method comprises a back plate, a shifting mechanism and a reagent filling module, the shifting mechanism and the reagent filling module are sequentially and fixedly arranged on the back plate, and a centrifugal column filtering module with a negative-pressure liquid pumping module is arranged at the bottom of the reagent filling module. Through a centrifugal column specifically combined with nucleic acid and a special reagent filling module, after a sample is subjected to cracking and protease K digestion treatment, nucleic acid in the sample is rapidly adsorbed and rapidly washed through a filter membrane, so that protein, pigments, lipids and other impurities are removed to the maximum extent; the obtained total nucleic acid can be stored in an eluent for a long time to be used for a next experiment. The whole device can realize centrifugal column method large-volume free nucleic acid automatic extraction for extracting, enriching and purifying the free total nucleic acid from fresh or frozen serum, plasma, lymph and other cell-free body fluids.
Owner:SHANGHAI JIAOTONG UNIV

Method for analyzing antibody

PCT designated stageWO2026079160A1Material analysis by electric/magnetic meansDigestionPorosome
Provided is a novel antibody analysis method that does not require capture or immobilization through an Fc structure. Specifically provided is a method for preparing a peptide fragment, the method comprising: a substrate immobilization step in which a target substrate antibody 125 in a biological sample is immobilized in a pore 129 of a porous body 120 that has affinity for a Fab domain of the substrate antibody 125; and a digestion step in which the porous body 120 on which the substrate antibody 125 has been immobilized is brought into contact with fine particles 110 each having a surface on which a protease 115 has been immobilized, whereby the digestion of the substrate antibody 125 with the protease is performed and a peptide fragment of the Fab domain is produced. In the substrate immobilization step, the Fab domain of the substrate antibody 125 is immobilized in the pore 129 of the porous body 120, and the average particle diameter D11 of the fine particles 110 is larger than the average pore diameter D12 of the porous body 120.
Owner:SHIMADZU CORP

Method for verifying whether sialic acid glycoform analysis result is accurate or not

The invention relates to a method for verifying whether a sialic acid glycotype analysis result is accurate or not, and the method for verifying whether the sialic acid glycotype analysis result is accurate or not comprises the following steps: carrying out desugaring, protease digestion and / or acid hydrolysis on glycoprotein by using a preset glycotype analysis method, and detecting whether the glycoprotein is completely desugarized or not so as to confirm whether the sialic acid glycotype analysis result is accurate or not, the glycoprotein contains sialic acid. According to the quality control method established by the invention, the analysis means of the current sialic acid sugar type-containing complex glycoprotein is perfected and improved, the accuracy of a detection result is ensured, and the quality control method is used for evaluating whether data can represent the real quality attribute of molecules or not, contributes to risk control and perfects a characterization research scheme.
Owner:SHANGHAI AUSCON BIOPHARMACEUTICAL CO LTD